A detailed history of Bayforest Capital LTD transactions in Boston Scientific Corp stock. As of the latest transaction made, Bayforest Capital LTD holds 2,263 shares of BSX stock, worth $217,745. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,263
Previous 370 511.62%
Holding current value
$217,745
Previous $37.3 Million 551.21%
% of portfolio
0.11%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 28, 2025

BUY
$89.7 - $107.41 $169,802 - $203,327
1,893 Added 511.62%
2,263 $243 Million
Q1 2025

May 08, 2025

SELL
$89.38 - $106.18 $17,339 - $20,598
-194 Reduced 34.4%
370 $0
Q4 2024

Feb 14, 2025

BUY
$83.62 - $91.5 $47,161 - $51,606
564 New
564 $50.4 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $138B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Bayforest Capital LTD Portfolio

Follow Bayforest Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayforest Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Bayforest Capital LTD with notifications on news.